Cited by 1,134Liver physiology and pathologyFibroblast Growth Factor ResearchHepatocellular Carcinoma Treatment and Prognosis

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats

Nakamura, Toshikazu, Nawa, Katsuhiko, Ichihara, Akira·1984·Biochemical and Biophysical Research Communications

Abstract

When rat serum was subjected to gel filtration on a Sephadex G-200 column, a factor, "hepatotropin", that promoted hepatocyte growth in primary culture was separated. Its Mr was about 150 KD and it was an anionic protein that was unstable on acid- and heat-treatments. Hepatotropin was purified 20-fold further by affinity chromatography on heparin-Sepharose CL-6B. The purified hepatotropin was effective at 20 micrograms/ml and maximally effective at 120 micrograms/ml, and its effect was additive with that of insulin plus epidermal growth factor. In rats after partial hepatectomy, the hepatotropin activity in the serum increased time-dependently reaching a maximum of about 5-fold the initial level 24 h after the operation. Various known growth factors, such as fibroblast growth factor, platelet derived growth factor, somatomedin, thrombin and transferrin, did not stimulate DNA synthesis in cultured hepatocytes. These results suggest that hepatotropin is a new growth factor.

Integrity signals

Registry

Crossref · 10.1016/0006-291x(84)91253-1

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nakamura, T., Nawa, K., & Ichihara, A.
Affiliations
Tokushima University (JP)
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
1984-08
Volume
122
Issue
3
Pages
1450-1459
ISSN
0006-291X (ISSN-L)
OpenAlex
W2048367533
Cited by
1,134
References
1
Citations by year
2026: 4 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 17 · 2021: 8 · 2020: 26 · 2019: 10 · 2018: 17 · 2017: 21 · 2016: 8 · 2015: 29 · 2014: 22 · 2013: 25 · 2012: 33
FWCI
12.45
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical and Biophysical Research Communications (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
hepatocyte growth factor, partial hepatectomy, serum growth factors, hepatocyte proliferation, anionic proteins
MeSH terms
Animals, Blood Platelets, Cells, Cultured, Chromatography, Affinity, Chromatography, Gel, DNA Replication, Growth Substances, Liver, Liver Regeneration, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review